Mylan Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS, and what generic and branded alternatives to MYLAN LABS drugs are available?
MYLAN LABS has one hundred and forty-eight approved drugs.
There are eleven tentative approvals on MYLAN LABS drugs.
Drugs and US Patents for Mylan Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Labs Ltd | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 091599-002 | Mar 12, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 091063-001 | Nov 9, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | NALOXONE HYDROCHLORIDE | naloxone hydrochloride | INJECTABLE;INJECTION | 213843-001 | Jun 9, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.